U.S. Capital Wealth Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio CNBS Stock Details CNBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23	Closed	-$1.37K	–	804
2022 Q4	$1.37K	Buy	+23	New	+$1.78K	﹤0.01%	1515

Other funds holding CNBS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

U.S. Capital Wealth Advisors's CNBS Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q1 2023, closing a stake of 23 shares — an estimated $1.37K sold.

U.S. Capital Wealth Advisors first reported a position in CNBS in Q4 2022 and held it in 1 quarter. The position peaked at $1.37K in Q4 2022. 32 funds tracked by Wall St. Rank hold CNBS as of Q1 2023.

U.S. Capital Wealth Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q1 2023 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 23 Amplify Seymour Cannabis ETF shares in Q1 2023, an estimated $1.37K.
U.S. Capital Wealth Advisors first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and held it in 1 quarter.
U.S. Capital Wealth Advisors's Amplify Seymour Cannabis ETF position peaked at $1.37K in Q4 2022.
32 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.